When was Penumbra founded?

Penumbra was founded in 2004 and raised its 1st funding round 8 years after it was founded.

Where is Penumbra located?

Penumbra is headquartered in Alameda, United States.

Which legal entities is Penumbra associated with?

Penumbra is associated with Penumbra OÜ and 2 others.

How many employees does Penumbra have?

As of Aug 31, 2026, the latest employee count at Penumbra is 3234.

Is Penumbra a funded company?

Penumbra is a funded company, having raised a total of $121K across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 01, 2012.

When was the latest funding round of Penumbra?

Penumbra's latest funding was a $***** Post IPO round on May 28, 2020, with participation from 0 investor.

What is the annual revenue of Penumbra?

Annual revenue of Penumbra is more than $1B as on Dec 31, 2025

Where does Penumbra rank among its competitors?

Penumbra ranks 2nd amongst 82 active competitors, of which 26 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was XCath, which secured $30M in Mar, 2026.

Who are the top competitors of Penumbra?

Penumbra's top competitors include Rapid Medical, Pulnovo Medical and SoniVie. Among them, XCath secured the most recent funding round in March, 2026.

Penumbra - 2026 Company Profile, Funding, Competitors & Financials

Penumbra is an acquired company based in Alameda (United States), founded in 2004. It operates as a Developer of medical devices for neurovascular and peripheral thrombectomy. Penumbra has raised $121K in funding. The company has 82 active competitors, including 26 funded and 21 that have exited. Its top competitors include companies like Rapid Medical, Pulnovo Medical and SoniVie.

Company Details

Developer of medical devices for neurovascular and peripheral thrombectomy. The company manufactures and supplies catheters, aspiration pumps, and related equipment used in minimally invasive procedures to treat stroke and other vascular occlusions. These devices are designed to remove blood clots, restoring blood flow to affected areas. The company also provides clinical evidence and resources to support healthcare providers using its technology. Its product line includes systems for both neurovascular and peripheral applications.

Website: penumbrainc.com
Social

Key Metrics

Founded Year

2004

Location

Alameda, United States

Stage

Acquired

Total Funding

$121K in 2 rounds

Latest Funding Round

Post IPO, May 28, 2020, $*****

Investors

Novo Holdings & 5 more

Ranked

2^nd among 82 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

3,234 as on Aug 31, 2026

Investment & Acquisitions

Magnendo

Similar Companies

Rapid Medical & 78 more

Exit Details

Acquired by Boston Scientific (Jan 15, 2026)

View Penumbra's full profile

Penumbra is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Penumbra OÜ CIN: 16161231 , Estonia, Active	Feb 14, 2021	-	-
Penumbra, Inc CIN: 05-0605598 , United States, Active	Jun 20, 2004	-	4200 (As on Dec 31, 2023)	-
PENUMBRA INC CIN: 1321732 , United States, Active	Jun 20, 2004	$1B+ (As on Dec 31, 2025)	4200 (As on Dec 31, 2023)	-

Penumbra got acquired by Boston Scientific on Jan 15, 2026.

Click here to take a look at Penumbra's acquisition in detail

Penumbra has raised a total funding of $121K over 2 rounds. Its first funding round was on Jan 01, 2012. Penumbra has 6 institutional investors.

Here is the list of recent funding rounds of Penumbra:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 28, 2020	8500851	Post IPO	8578937	4435458	2684669	3656296
Jan 01, 2012	8039985	Seed	4945760	3883188	4824908	8556427

Access funding benchmarks and valuations. Sign up today!

View details of Penumbra's funding rounds and investors

Penumbra's employee count trend

Penumbra has 3,234 employees as of Aug 26. Here is Penumbra's employee count trend over the years:

Uncover Penumbra's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Penumbra include Rapid Medical, Pulnovo Medical and SoniVie. Here is the list of Top 10 competitors of Penumbra, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Rapid Medical 2008, Yokneam Illit (Israel), Series D	Developer of neurovascular interventional devices such as distal access & microcatheters	$79M	MicroPort Orthopedics, BRM & 9 others	65/100
2nd	Penumbra 2004, Alameda (United States), Acquired	Developer of medical devices for neurovascular and peripheral thrombectomy	$121K	Novo Holdings, The Angels’ Forum & 4 others	63/100
3rd	Pulnovo Medical 2013, Wuxi (China), Series C	Developer of a medical device for the treatment of pulmonary hypertension	$115M	LAV Asset Management, Qiming Venture Partners ... & 8 others	54/100
4th	SoniVie 2014, Rosh Haayin (Israel), Acquired	Developer of denervation catheter for the treatment of pulmonary hypertension	$62.5M	Andera Partners, Accelmed & 6 others	51/100
5th	Cerevast 2009, Bothell (United States), Series C	Medical device company developing innovative ultrasound and microsphere therapies	$46.9M	Swiftsure, Haiyin Capital	50/100
6th	XCath 2017, Houston (United States), Series C	Developer of endovascular robotics and steerable guidewires	$92M	Crescent Enterprises & 1 others	49/100
7th	Sequent Medical 2007, Aliso Viejo (United States), Acquired	Catheter-based neurovascular devices	$65.3M	Delphi Ventures, Versant Ventures & 4 others	49/100
8th	BTG International 1948, London (United Kingdom), Acquired	Developer of therapeutics for oncology, pulmonology, hematology and anti-venom	-	Novo Holdings, Blue HK Investments & 1 others	48/100
9th	Aria CV 2010, Saint Paul (United States), Series B	Device for pulmonary hypertension	$45M	Xeraya Capital, CHV & 10 others	47/100
10th	Terumo Neuro 1997, Aliso Viejo (United States), Unfunded	Developer of minimally-invasive devices for the treatment of vascular diseases in the brain	-	-	46/100